Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.135 AUD | 0.00% | +3.85% | -20.59% |
08/04 | Starpharma, Medicxi Co-Found Petalion Therapeutics; Shares Surge 16% | MT |
18/03 | Starpharma Holdings Limited(ASX:SPL) dropped from S&P/ASX Emerging Companies Index | CI |
Chart calendar Starpharma Holdings Limited
Upcoming events on Starpharma Holdings Limited
Past events on Starpharma Holdings Limited
09/04/2024 06:30 am | Starpharma Holdings Ltd. and Medicxi Strategic Partnership Call |
28/02/2024 04:08 am | Q2 2024 Earnings Release |
31/01/2024 04:04 am | December 2023 Sales and Revenue Release - Activities Report |
29/11/2023 08:30 am | Annual General Meeting |
14/11/2023 | Bell Potter Healthcare Conference |
31/10/2023 04:15 am | September 2023 Sales and Revenue Release - Activities Report |
27/10/2023 | Wilsons Drug and Device Conference |
14/10/2023 | AACR-NCI-EORTC International Conference - Poster No : C167 |
13/10/2023 | AACR-NCI-EORTC International Conference - Poster No : B039 |
12/10/2023 | AACR-NCI-EORTC International Conference - Poster No : A147 |
11/10/2023 | AACR-NCI-EORTC International Conference |
22/09/2023 09:30 am | Share Cafes Hidden Gems Webinar |
24/08/2023 05:07 am | Q4 2023 Earnings Release |
31/07/2023 05:23 am | June 2023 Sales and Revenue Release - Activities Report |
22/06/2023 07:30 pm | OTC Life Science Investor Forum |
08/06/2023 | European Hematology Association Hybrid Congress |
28/04/2023 05:01 am | March 2023 Sales and Revenue Release - Activities Report |
22/03/2023 | ASX Small and Mid-Cap Conference |
28/02/2023 03:59 am | Q2 2023 Earnings Release |
30/01/2023 | December 2022 Sales and Revenue Release - Activities Report |
Annual results
Fiscal Period | Juni | 2019 | 2020 | 2022 |
---|---|---|---|---|
Net sales Million AUD | Released Forecast Spread | 6,72 5,69 18.22% | 7,12 10,2 -30.23% | 0,00 |
EBITDA Million AUD | Released Forecast Spread | -15,0 -13,1 -14.44% | -14,8 -13,8 -7.85% | 0,00 |
EBIT Million AUD | Released Forecast Spread | -15,3 -13,5 -13.62% | -15,8 -14,1 -11.85% | 0,00 |
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -14,3 -13,0 -9.75% | -14,7 -13,1 -11.73% | 0,00 |
Net income Million AUD | Released Forecast Spread | -14,3 -13,0 -9.75% | -14,7 -13,1 -11.73% | -16,2 |
EPS AUD | Released Forecast Spread | -0,04 -0,04 1.23% | -0,04 -0,04 -2.96% | -0,04 |
Announcement Date | 28/08/19 | 26/08/20 | 24/08/22 |
Quarterly results
Fiscal Period | Juni | 2020 S1 | 2020 S2 | 2021 S1 | 2023 S1 |
---|---|---|---|---|---|
Net sales Million AUD | Released Forecast Spread | 5,67 | 1,61 9,00 -82.14% | ||
EBITDA Million AUD | Released Forecast Spread | -9,12 -10,3 11.42% | |||
EBIT Million AUD | Released Forecast Spread | -9,58 -10,5 8.77% | -8,28 -5,30 -56.17% | ||
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -8,82 -8,90 0.96% | -10,4 -9,90 -5.35% | ||
Net income Million AUD | Released Forecast Spread | -8,82 -8,90 0.96% | -10,4 -9,90 -5.35% | -8,28 -5,30 -56.17% | |
EPS AUD | Released Forecast Spread | -0,02 | |||
Announcement Date | 23/02/20 | 26/08/20 | 24/02/21 | 27/02/23 |
Past sector events for Starpharma Holdings Limited
Annual profits - Rate of surprise
- Stock Market
- Equities
- SPL Stock
- Calendar Starpharma Holdings Limited